MiMedx Group Inc. (NASDAQ:MDXG) saw an upside of 1.78% to close Friday at $7.44 after adding $0.13 on the day. The 5-day average trading volume is 484,920 shares of the company’s common stock. It has gained $7.63 in the past week and touched a new high 2 times within the past 5 days. An average of 776,685 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 907,948.
MDXG’s 1-month performance is -1.06% or -$0.20 on its low of $7.15 reached on 08/18/23. The company’s shares have touched a 52-week low of $2.43 and high of $8.60, with the stock’s rally to the 52-week high happening on 08/02/23. YTD, MDXG has achieved 167.63% or $4.66 and has reached a new high 39 times. However, the current price is down -13.49% from the 52-week high price.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
MDXG stock investors last saw insider trading activity on May 16.Stein Robert Benjamin (President, Regenerative Med.) most recently sold 10,365 shares at $5.95 per share on May 16. This transaction cost the insider $61,627. President, Regenerative Med., Stein Robert Benjamin, sold 3,607 shares at a price of $6.15 on May 15. Then, on May 10, Chief Financial Officer Carlson Peter M sold 5,976 shares at a price of $5.93 per share. This transaction amounted to $35,414.
Valuation Metrics
MDXG stock has a beta of 1.61. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 2.88.
MiMedx Group Inc.’s quick ratio for the period ended June 29 was 2.80, with the current ratio over the same period at 3.20. In terms of profitability, the gross margin trailing 12 months is 82.20%. The trailing 12-month EBITDA margin is -7.34% while for the period ending June 29, MiMedx Group Inc.’s operating margin was -2.20%. The firm’s gross profit as reported stood at $219.53 million against revenue of $267.84 million.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income shrunk -2258.49% to -$0.53 million, while revenue of -$6.67 million was -1158.49% off the previous quarter. Analysts expected MDXG to announce -$0.02 per share in earnings in its latest quarter, but it posted $0, representing a 100.00% surprise. EBITDA for the quarter stood at more than $4.32 million. MDXG stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 189.04 million, with total debt at $50.9 million. Shareholders hold equity totaling $116.11 million.
Let’s look briefly at MiMedx Group Inc. (MDXG) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 18 August was 48.87% to suggest the stock is trending Neutral, with historical volatility in this time period at 22.24%.
The stock’s 5-day moving average is $7.41, reflecting a -1.46% or -$0.11 change from its current price. MDXG is currently trading -2.11% above its 20-day SMA, +118.18% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +28.72% and SMA200 by+151.35%.
Stochastic %K and %D was 10.64% and 11.04% and the average true range (ATR) pointed at 0.31. The RSI (14) points at 52.97%, while the 14-day stochastic is at 20.00% with the period’s ATR at 0.32. The stock’s 9-day MACD Oscillator is pointing at -0.07 and -0.17 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for MiMedx Group Inc. (NASDAQ: MDXG), Mizuho launched coverage with a Buy rating. Analysts offering their rating for MDXG stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate MDXG as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 3 have offered a “buy” rating.
What is MDXG’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $11.00 and a high of $14.00, with their median price target at $11.63. Looking at these predictions, the average price target given by analysts is for MiMedx Group Inc. (MDXG) stock is $12.06.
